Therefore, investigating the effects of cladribine on the differentiation of both M-CSF and GM-CSF-derived MDMs could reveal the effects of cladribine on monocytes and their derivatives present in different types of MS lesions. Here, CSF2 is linked to myeloid sarcoma.